RAMPART
Phase NA Completed
40 enrolled
TraveraRTGx
Completed
72 enrolled
Clinical Validation of AI-Assisted Radiotherapy Contouring Software for Thoracic Organs at Risk
Completed
500 enrolled
A Safety and Efficacy Study Evaluating CTX131 in Adult Subjects With Relapsed or Refractory Solid Tumors
Phase 1/2 Completed
19 enrolled
ARC-12
Phase 1 Completed
94 enrolled
EARN
Phase NA Completed
33 enrolled
DELFI-L101
Completed
2,992 enrolled
Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies
Phase 1 Completed
23 enrolled
A Study of CDX-585 in Patients With Advanced Malignancies
Phase 1 Completed
20 enrolled
Study of NGM120 in Subjects With Advanced Solid Tumors, Pancreatic Cancer, and Prostate Cancer Using Combination Therapy
Phase 1/2 Completed
89 enrolled 21 charts
ABIMMUNE
Phase 1/2 Completed
54 enrolled
A Study to Evaluate the Clinical Efficacy of JNJ-42756493 (Erdafitinib), A Pan-Fibroblast Growth Factor Receptor (FGFR) Tyrosine Kinase Inhibitor, In Asian Participants With Advanced Non-Small-Cell Lung Cancer, Urothelial Cancer, Esophageal Cancer Or Cholangiocarcinoma
Phase 2 Completed
35 enrolled
Dose Escalation of RMC-5552 Monotherapy in Relapsed/Refractory Solid Tumors
Phase 1 Completed
58 enrolled
Genomic Testing and Resulting Medical Decisions
Completed
1,500 enrolled
PREFER
Completed
1,429 enrolled
MOM
Completed
40 enrolled
Early Palliative Care With Standard Care or Standard Care Alone in Improving Quality of Life of Patients With Incurable Lung or Non-colorectal Gastrointestinal Cancer and Their Family Caregivers
Phase 3 Completed
405 enrolled 11 charts
CARMA
Phase NA Completed
20 enrolled
ACTolog
Phase 1 Completed
38 enrolled
A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Phase 1 Completed
112 enrolled
Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer
Phase NA Completed
128 enrolled 24 charts
Study to Assess Safety, Tolerability and Clinical Activity of BGB-290 in Combination With Temozolomide (TMZ) in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Completed
139 enrolled 36 charts
ROOT
Completed
167 enrolled
A First in Human, Dose Escalation Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors
Phase 1 Completed
38 enrolled
Sym024 Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies
Phase 1 Completed
48 enrolled
Phase I Dose Escalation Study for VIP152 in Patients With Advanced Cancer
Phase 1 Completed
110 enrolled
A Prospective Study Frailty for Esophagectomy and Lung Resection in Thoracic Surgery
Completed
360 enrolled
BT1718 in Patients with Advanced Solid Tumours.
Phase 1/2 Completed
72 enrolled
A First-in-Human Study of JAB-3068 (SHP2 Inhibitor) in Adult Patients With Advanced Solid Tumors in China
Phase 1/2 Completed
126 enrolled
POISE
Phase 3 Completed
22 enrolled
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Phase 1/2 Completed
78 enrolled 15 charts
Multimodal Assesment of Acute Cardiac Toxicity Induced by Thoracic Radiotherapy in Cancer Patients
Completed
47 enrolled
A Study of CDX-1140 (CD40) as Monotherapy or in Combination in Patients With Advanced Malignancies
Phase 1 Completed
132 enrolled
Radiogenomics in Aerodigestive Tract Cancers
Completed
139 enrolled
ABC
Phase NA Completed
22 enrolled
PROCLAIM-CX-2029: A Trial to Find Safe and Active Doses of an Investigational Drug CX-2029 for Patients With Solid Tumors or DLBCL
Phase 1/2 Completed
133 enrolled
MORRIS
Completed
118 enrolled
Early Palliative Care in Advanced Lung and Gastrointestinal Malignancies
Phase NA Completed
351 enrolled 15 charts
M1231 in Participants With Solid Tumors
Phase 1 Completed
23 enrolled
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
Phase 1 Completed
27 enrolled
TOGA
Completed
14 enrolled
A Study of PRT1419 in Patients With Advanced Solid Tumors
Phase 1 Completed
26 enrolled
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S
Phase 1 Completed
15 enrolled
NY-ESO-1 Plasmid DNA (pPJV7611) Cancer Vaccine
Phase 1 Completed
18 enrolled 12 charts
A Study Exploring the Safety and Efficacy of INCAGN01949 in Combination With Immune Therapies in Advanced or Metastatic Malignancies
Phase 1/2 Completed
52 enrolled 25 charts
Blood Sample Collection to Evaluate Biomarkers in Subjects With Untreated Solid Tumors
Completed
5,133 enrolled
trūFreeze® Spray Cryotherapy Patient Registry
Completed
275 enrolled
Minimizing Pathologic Aspiration in Patients Undergoing Esophageal and Lung Resections for Cancer
Phase NA Completed
49 enrolled
RAV12 in Treating Patients With Metastatic or Recurrent Adenocarcinoma
Phase 1 Completed
53 enrolled
177Lu-J591 Antibody in Patients With Nonprostate Metastatic Solid Tumors
Phase 1 Completed
20 enrolled